Literature DB >> 26652282

Nanostructured materials for ocular delivery: nanodesign for enhanced bioadhesion, transepithelial permeability and sustained delivery.

Jean Kim1, Erica B Schlesinger1, Tejal A Desai2.   

Abstract

Effective drug delivery to the eye is an ongoing challenge due to poor patient compliance coupled with numerous physiological barriers. Eye drops for the front of the eye and ocular injections for the back of the eye are the most prevalent delivery methods, both of which require relatively frequent administration and are burdensome to the patient. Novel drug delivery techniques stand to drastically improve safety, efficacy and patient compliance for ocular therapeutics. Remarkable advances in nanofabrication technologies make the application of nanostructured materials to ocular drug delivery possible. This article focuses on the use of nanostructured materials with nanoporosity or nanotopography for ocular delivery. Specifically, we discuss nanotopography for enhanced bioadhesion and permeation and nanoporous materials for controlled release drug delivery. As examples, application of polymeric nanostructures for greater transepithelial permeability, nanostructured microparticles for enhanced preocular retention time and nanoporous membranes for tuning drug release profile are covered.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26652282      PMCID: PMC4893795          DOI: 10.4155/tde.15.75

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  51 in total

1.  An evaluation of cultivated corneal limbal epithelial cells, using cell-suspension culture.

Authors:  Noriko Koizumi; Leanne J Cooper; Nigel J Fullwood; Takahiro Nakamura; Keiko Inoki; Masakatsu Tsuzuki; Shigeru Kinoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

Review 2.  The use of mucoadhesive polymers in ocular drug delivery.

Authors:  Annick Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2005-09-28       Impact factor: 15.470

3.  Nanoengineered surfaces enhance drug loading and adhesion.

Authors:  Kathleen E Fischer; Aishwarya Jayagopal; Ganesh Nagaraj; R Hugh Daniels; Esther M Li; Matthew T Silvestrini; Tejal A Desai
Journal:  Nano Lett       Date:  2011-01-31       Impact factor: 11.189

Review 4.  Chitosan-based nanostructures: a delivery platform for ocular therapeutics.

Authors:  Maria de la Fuente; Manuela Raviña; Patrizia Paolicelli; Alejandro Sanchez; Begoña Seijo; Maria Jose Alonso
Journal:  Adv Drug Deliv Rev       Date:  2009-12-01       Impact factor: 15.470

5.  In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.

Authors:  S Yee
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

6.  Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers.

Authors:  Amy B Foraker; Rob J Walczak; Michael H Cohen; Tony A Boiarski; Carl F Grove; Peter W Swaan
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

7.  Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time.

Authors:  Young Bin Choy; Jung-Hwan Park; Bernard E McCarey; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

8.  Coated microneedles for drug delivery to the eye.

Authors:  Jason Jiang; Harvinder S Gill; Deepta Ghate; Bernard E McCarey; Samir R Patel; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

9.  Nanostructured thin film polymer devices for constant-rate protein delivery.

Authors:  Daniel A Bernards; Kevin D Lance; Natalie A Ciaccio; Tejal A Desai
Journal:  Nano Lett       Date:  2012-09-19       Impact factor: 11.189

10.  Intrascleral drug delivery to the eye using hollow microneedles.

Authors:  Jason Jiang; Jason S Moore; Henry F Edelhauser; Mark R Prausnitz
Journal:  Pharm Res       Date:  2008-11-01       Impact factor: 4.200

View more
  7 in total

1.  TiO2-Based Nanotopographical Cues Attenuate the Restenotic Phenotype in Primary Human Vascular Endothelial and Smooth Muscle Cells.

Authors:  Yiqi Cao; Tejal A Desai
Journal:  ACS Biomater Sci Eng       Date:  2020-01-17

Review 2.  Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Authors:  Abhirup Mandal; Dhananjay Pal; Vibhuti Agrahari; Hoang My Trinh; Mary Joseph; Ashim K Mitra
Journal:  Adv Drug Deliv Rev       Date:  2018-01-13       Impact factor: 15.470

3.  Design and fabrication of drug-eluting polymeric thin films for applications in ophthalmology.

Authors:  Lampros Lamprogiannis; Athanasios Karamitsos; Varvara Karagkiozaki; Ioannis Tsinopoulos; Maria Gioti; Dimitrios G Fatouros; Stavros Dimitrakos; Stergios Logothetidis
Journal:  IET Nanobiotechnol       Date:  2018-12       Impact factor: 1.847

Review 4.  Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.

Authors:  Rinda Devi Bachu; Pallabitha Chowdhury; Zahraa H F Al-Saedi; Pradeep K Karla; Sai H S Boddu
Journal:  Pharmaceutics       Date:  2018-02-27       Impact factor: 6.321

Review 5.  Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease.

Authors:  Yilin Guo; Shiyu Zong; Yiqiong Pu; Benliang Xu; Tong Zhang; Bing Wang
Journal:  Molecules       Date:  2018-07-04       Impact factor: 4.411

Review 6.  Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery.

Authors:  Rajiv Bajracharya; Jae Geun Song; Seung Yun Back; Hyo-Kyung Han
Journal:  Comput Struct Biotechnol J       Date:  2019-09-11       Impact factor: 7.271

7.  Core/shell nanoassembly of amphiphilic naproxen-polyethylene glycol: synthesis, characterisation and evaluation as drug delivery system.

Authors:  Srishti Munjal; Smriti R Deka; Santosh Yadav; Preeti Goyal; Ashwani K Sharma; Pradeep Kumar
Journal:  IET Nanobiotechnol       Date:  2018-09       Impact factor: 1.847

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.